Showing results (691-700 of 1,359) with videos related to

Sort By:
Pageof 136
Haemostasis|January 1, 1978
Current concepts on action of synthetic thrombin inhibitorsJ D Geratz, R R Tidwell
Haemostasis|January 1, 1988
Effect of anti plasminogen monoclonal antibodies on whole blood clot lysisF Ehrenreich, E Hattey, J Wojta, et al.
Haemostasis|January 1, 1988
Reference values and variability of plasminogen in healthy blood donors and its relation to parameters of the fibrinolytic systemG Leipnitz, C Miyashita, M Heiden, et al.
Haemostasis|March 9, 1999
The economic impact of treating deep vein thrombosis with low-molecular-weight heparin: outcome of therapy and health economy aspectsR D Hull, G F Pineo, G E Raskob
Haemostasis|March 9, 1999
Thromboprophylaxis in non-surgical patients: who, when and how?A S Gallus, M Nurmohamed, M Nurmohammed, et al.
Haemostasis|March 9, 1999
Unfractionated heparin and low-molecular-weight heparin for the initial treatment of acute venous thromboembolismP Prandoni
Haemostasis|March 9, 1999
Out-of-hospital treatment of venous thrombosis: socioeconomic aspects and patients' quality of lifeP M Bossuyt, A G van den Belt, M H Prins
Haemostasis|March 9, 1999
Symptomatic endpoints for venous thromboembolism treatmentD R Anderson
Haemostasis|March 24, 1999
Randomized assessment of a warfarin nomogram for initial oral anticoagulation after venous thromboembolic diseaseM J Kovacs, M Cruickshank, P S Wells, et al.
Haemostasis|March 24, 1999
Early versus delayed introduction of oral vitamin K antagonists in combination with low-molecular-weight heparin in the treatment of deep vein thrombosis. a randomized clinical trial. The ANTENOX Study GroupC Leroyer, L Bressollette, E Oger, et al.
Pageof 136